FOR IMMEDIATE RELEASE
Statement attributable to:
Beth Feldpush, DrPH
Senior Vice President of Policy and Advocacy
America’s Essential Hospitals
WASHINGTON — We are pleased the Centers for Medicare & Medicaid Services clearly has stated its intention to fully restore payments for 340B-acquired drugs in the calendar year 2023 Outpatient Prospective Payment System (OPPS) proposed rule.
This is an important step toward reversing the damage caused by deep cuts to payments for outpatient drugs acquired through the 340B Drug Pricing Program — cuts the U.S. Supreme Court unanimously found unlawful. We now must turn to a timely remedy that reinstates payments critical to essential hospitals’ efforts to advance access and improve health equity.
# # #
About America’s Essential Hospitals
America’s Essential Hospitals is the leading association and champion for hospitals dedicated to equitable, high-quality care for all, including those who face social and financial barriers to care. Since 1981, America’s Essential Hospitals has advanced policies and programs that promote health, health care access, and equity. We support our more than 300 members with advocacy, policy development, research, education, and leadership development. Communities depend on essential hospitals for care across the continuum, health care workforce training, research, public health and health equity, and other services. Essential hospitals innovate and adapt to lead all of health care toward better outcomes and value. Learn more at essentialhospitals.org.
Contact:
Carl Graziano
cgraziano@essentialhospitals.org
202.585.0102
Author